Trastuzumab Active Not Recruiting Phase N/A Trials for Lung Cancer Metastatic / Stage IV Breast Cancer / Bone Metastases / Her2-Positive Breast Cancer / Recurrent Breast Cancer / Soft Tissue Metastases / Hepatic Metastases Diagnostic

IndicationsStatusPurposePhase
Active Not RecruitingDiagnosticNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02226276Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer